This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
MilliporeSigma
other brands :
FLUKA, Sigma-Aldrich, Roche Applied Science
product type :
protein
product name :
Thrombin Receptor Activator Peptide 6
catalog :
T1573
citations: 30
Reference
Adair B, Alonso J, van Agthoven J, Hayes V, Ahn H, Yu I, et al. Structure-guided design of pure orthosteric inhibitors of αIIbβ3 that prevent thrombosis but preserve hemostasis. Nat Commun. 2020;11:398 pubmed publisher
Bukowska A, Schild L, Bornfleth P, Peter D, Wiese Rischke C, Gardemann A, et al. Activated clotting factor X mediates mitochondrial alterations and inflammatory responses via protease-activated receptor signaling in alveolar epithelial cells. Eur J Pharmacol. 2020;869:172875 pubmed publisher
Peshkova A, Safiullina S, Evtugina N, Baras Y, Ataullakhanov F, Weisel J, et al. Premorbid Hemostasis in Women with a History of Pregnancy Loss. Thromb Haemost. 2019;119:1994-2004 pubmed publisher
Spoerri P, Sapra K, Zhang C, Mari S, Kato H, Kobilka B, et al. Conformational Plasticity of Human Protease-Activated Receptor 1 upon Antagonist- and Agonist-Binding. Structure. 2019;27:1517-1526.e3 pubmed publisher
Migkos T, Applova L, Horký P, Tvrdý V, Karlíčková J, Macakova K, et al. The influence of microbial isoflavonoid specific metabolites on platelets and transition metals iron and copper. Phytomedicine. 2019;62:152974 pubmed publisher
Braathen H, Sivertsen J, Lunde T, Kristoffersen E, Assmus J, Hervig T, et al. In vitro quality and platelet function of cold and delayed cold storage of apheresis platelet concentrates in platelet additive solution for 21 days. Transfusion. 2019;59:2652-2661 pubmed publisher
Pang J, Hu P, Wang J, Jiang J, Lai J. Vorapaxar stabilizes permeability of the endothelial barrier under cholesterol stimulation via the AKT/JNK and NF‑κB signaling pathways. Mol Med Rep. 2019;19:5291-5300 pubmed publisher
Navred K, Martin M, Ekdahl L, Zetterberg E, Andersson N, Strandberg K, et al. A simplified flow cytometric method for detection of inherited platelet disorders-A comparison to the gold standard light transmission aggregometry. PLoS ONE. 2019;14:e0211130 pubmed publisher
Rigg R, Healy L, Chu T, Ngo A, Mitrugno A, Zilberman Rudenko J, et al. Protease-activated receptor 4 activity promotes platelet granule release and platelet-leukocyte interactions. Platelets. 2019;30:126-135 pubmed publisher
Charest Morin X, Hebert J, Rivard G, Bonnefoy A, Wagner E, Marceau F. Comparing Pathways of Bradykinin Formation in Whole Blood From Healthy Volunteers and Patients With Hereditary Angioedema Due to C1 Inhibitor Deficiency. Front Immunol. 2018;9:2183 pubmed publisher
Ito Y, Nakamura S, Sugimoto N, Shigemori T, Kato Y, Ohno M, et al. Turbulence Activates Platelet Biogenesis to Enable Clinical Scale Ex Vivo Production. Cell. 2018;174:636-648.e18 pubmed publisher
Passam F, Chiu J, Ju L, Pijning A, Jahan Z, Mor Cohen R, et al. Mechano-redox control of integrin de-adhesion. elife. 2018;7: pubmed publisher
Koessler J, Trulley V, Bosch A, Weber K, Koessler A, Böeck M, et al. The role of agonist-induced activation and inhibition for the regulation of purinergic receptor expression in human platelets. Thromb Res. 2018;168:40-46 pubmed publisher
Mitrugno A, Rigg R, Laschober N, Ngo A, Pang J, Williams C, et al. Potentiation of TRAP-6-induced platelet dense granule release by blockade of P2Y12 signaling with MRS2395. Platelets. 2018;29:383-394 pubmed publisher
Wand S, Adam E, Wetz A, Meybohm P, Kunze Szikszay N, Zacharowski K, et al. The Prevalence and Clinical Relevance of ASA Nonresponse After Cardiac Surgery: A Prospective Bicentric Study. Clin Appl Thromb Hemost. 2018;24:179-185 pubmed publisher
Alsmadi N, Shapiro S, Lewis C, Sheth V, Snyder T, Schmidtke D. Constricted microfluidic devices to study the effects of transient high shear exposure on platelets. Biomicrofluidics. 2017;11:064105 pubmed publisher
Koessler J, Schwarz M, Weber K, Etzel J, Koessler A, Böeck M, et al. The role of adenosine diphosphate mediated platelet responsiveness for the stability of platelet integrity in citrated whole blood under ex vivo conditions. PLoS ONE. 2017;12:e0188193 pubmed publisher
Moschonas I, Kellici T, Mavromoustakos T, Stathopoulos P, Tsikaris V, Magafa V, et al. Molecular requirements involving the human platelet protease-activated receptor-4 mechanism of activation by peptide analogues of its tethered-ligand. Platelets. 2017;28:812-821 pubmed publisher
Zilberman Rudenko J, Itakura A, Maddala J, Baker Groberg S, Vetter R, Tucker E, et al. Biorheology of platelet activation in the bloodstream distal to thrombus formation. Cell Mol Bioeng. 2016;9:496-508 pubmed publisher
Voigtlaender M, Holstein K, Spath B, Bokemeyer C, Langer F. Expression and release of platelet protein disulphide isomerase in patients with haemophilia A. Haemophilia. 2016;22:e537-e544 pubmed publisher
Rauzi F, Kirkby N, Edin M, Whiteford J, Zeldin D, Mitchell J, et al. Aspirin inhibits the production of proangiogenic 15(S)-HETE by platelet cyclooxygenase-1. FASEB J. 2016;30:4256-4266 pubmed
Stoetzer C, Nickel K, Weißig A, Großheim M, Scheinichen D, Doll T, et al. Olive Oil-Based Lipid Emulsions Do Not Influence Platelet Receptor Expression in Comparison to Medium and Long Chain Triglycerides In vitro. Lipids. 2016;51:1241-1248 pubmed
Meinke S, Sandgren P, Mörtberg A, Karlström C, Kadri N, Wikman A, et al. Platelets made HLA deficient by acid treatment aggregate normally and escape destruction by complement and phagocytes in the presence of HLA antibodies. Transfusion. 2016;56:370-82; quiz 369 pubmed publisher
Toka O, Tank J, Schächterle C, Aydin A, Maass P, Elitok S, et al. Clinical effects of phosphodiesterase 3A mutations in inherited hypertension with brachydactyly. Hypertension. 2015;66:800-8 pubmed publisher
Leitner G, List J, Horvath M, Eichelberger B, Panzer S, Jilma Stohlawetz P. Additive solutions differentially affect metabolic and functional parameters of platelet concentrates. Vox Sang. 2016;110:20-6 pubmed publisher
Gremmel T, Kopp C, Eichelberger B, Koppensteiner R, Panzer S. Sex differences of leukocyte-platelet interactions and on-treatment platelet reactivity in patients with atherosclerosis. Atherosclerosis. 2014;237:692-5 pubmed publisher
Gremmel T, Koppensteiner R, Kaider A, Eichelberger B, Mannhalter C, Panzer S. Impact of variables of the P-selectin - P-selectin glycoprotein ligand-1 axis on leukocyte-platelet interactions in cardiovascular disease. Thromb Haemost. 2015;113:806-12 pubmed publisher
Wauters A, Esmaeilzadeh F, Bladt S, Beukinga I, Wijns W, van de Borne P, et al. Pro-thrombotic effect of exercise in a polluted environment: a P-selectin- and CD63-related platelet activation effect. Thromb Haemost. 2015;113:118-24 pubmed publisher
Maugeri N, Campana L, Gavina M, Covino C, De Metrio M, Panciroli C, et al. Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps. J Thromb Haemost. 2014;12:2074-88 pubmed publisher
Delekta P, Apel I, Gu S, Siu K, Hattori Y, McAllister Lucas L, et al. Thrombin-dependent NF-{kappa}B activation and monocyte/endothelial adhesion are mediated by the CARMA3·Bcl10·MALT1 signalosome. J Biol Chem. 2010;285:41432-42 pubmed publisher
product information
Catalog Number :
T1573
Product Name :
Thrombin Receptor Activator Peptide 6
Product Type :
PROTEINS & ENZYMES
Product Group :
Protein & Pathway Technologies
Product Description :
>95% (HPLC)
company information
MilliporeSigma
PO Box 14508
St. Louis, MO 63178
https://www.sigmaaldrich.com
1-800-325-3010
headquarters: USA